Kymera Therapeutics, Inc. (KYMR)
87.71
+1.57
(+1.82%)
USD |
NASDAQ |
Apr 17, 16:00
87.67
-0.04
(-0.05%)
After-Hours: 20:00
Kymera Therapeutics SG&A Expense (Quarterly) : 16.94M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.418B |
| Revolution Medicines, Inc. | 66.68M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Indivior Pharmaceuticals, Inc. | 189.00M |
| Structure Therapeutics, Inc. | 17.65M |